Background NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …

A solution blow spinning technique was developed using elements of both electrospinning
and melt blowing technologies as an alternative method for making non‐woven webs of micro…

Background The loss of half the US supply of influenza vaccine due to contamination has
created a critical shortage. Dose-sparing strategies that use intradermal delivery of vaccines …

Transcutaneous immunization, a topical vaccine application, combines the advantages of
needle-free delivery while targeting the immunologically rich milieu of the skin. In animal …

Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…

All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of
generating protective neutralizing antibodies. The recent emergence and rapid spread of several …

Cross-Reactive Neutralization of SARS-CoV-2 Variants An analysis of cross-reactive viral
binding and neutralization of emerging SARS-CoV-2 variants, modeled with the use of …

Cellulose microfibrils obtained by the acid hydrolysis of cellulose fibers were added at low
concentrations (2–10% w/w) to polymer gels and films as reinforcing agents. Significant …

Abstract Development of vaccination strategies for emerging pathogens are particularly
challenging because of the sudden nature of their emergence and the long process needed for …

Background Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory
tract infection in infants, with the most severe cases concentrated among younger infants…